Institutional Ownership
Autolus Therapeutics PLC
CUSIP 05280R100SPON ADSAUTLQ1 2026
13D / 13G Filings
51
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
32.4%
Max % of class reported
Institutional Holders
84
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
51 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 6.6% | 17.50M | SEC |
| 2 | Feb 13, 2026 | Mak Capital Fund LP | 13G/A | 11.3% | 30.01M | SEC |
| 3 | Dec 3, 2025 | Mak Capital Fund LP | 13G/A | 10.1% | 26.89M | SEC |
| 4 | Nov 14, 2025 | Armistice Capital, LLC | 13G | 5.9% | 15.60M | SEC |
| 5 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 1.0% | 2.57M | SEC |
| 6 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 1.18M | SEC |
| 7 | Jun 25, 2025 | Mak Capital Fund LP | 13G | 5.8% | 15.41M | SEC |
| 8 | May 12, 2025 | Fmr LLC | 13G/A | 3.8% | 10.16M | SEC |
| 9 | May 7, 2025 | Syncona Portfolio Limited | 13G/A | 10.8% | 28.82M | SEC |
| 10 | Nov 14, 2024 | Syncona Portfolio Ltd | 13G/A | 11.6% | 30.73M | SEC |
41 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Autolus Therapeutics PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Mak Capital One LLC | 33.62M | $46.40M |
| 2 | Blackstone Inc. | 20.49M | $28.27M |
| 3 | Syncona Portfolio Ltd | 16.64M | $22.96M |
| 4 | Armistice Capital, LLC | 15.80M | $21.80M |
| 5 | Tetragon Partners Gp Ltd | 9.50M | $13.11M |
| 6 | Schroder Investment Management Group | 9.49M | $12.05M |
| 7 | Frazier Life Sciences Management, L.P. | 4.45M | $6.14M |
| 8 | Bnp Paribas Asset Management Holding S.A. | 3.36M | $4.64M |
| 9 | Laurion Capital Management LP | 3.32M | $4.58M |
| 10 | Renaissance Technologies LLC | 2.30M | $3.17M |